InvestigationsReporting
GLP-1 Drugs: What Happens When You Start, Stay On—or Stop? The Heart-Risk Study and Overlooked Side Effects
A new Italian study links discontinuing GLP-1 drugs to higher cardiovascular event rates but cannot establish cause. We examine rebound weight gain, gastrointestinal and muscle risks,…
Nov 10, 2026 | 11 min read
